Search

everythinglearnresearchcommunity

for

Search:↓

Compounded topical preparations should be used with caution for severe psoriasis and generally come after systemic treatments.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

Accidentally eating a topical steroid may rarely cause acute generalized pustular psoriasis.

Chronic kidney disease can cause skin issues that need early recognition and combined treatment for better outcomes.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

A 54-year-old man with painful skin blisters and fever was diagnosed with Sweet syndrome and successfully treated with corticosteroids.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Control symptoms and use safe treatments for skin conditions like lichen planopilaris and chronic cutaneous lupus erythematosus.

Minoxidil is effective for hair growth and safe for long-term use.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.